Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In this report, the Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Postpartum bleeding or postpartum hemorrhage (PPH) is characterized by the loss of more than 500 ml or 1,000 ml of blood within the first 24 hours following childbirth. PPH devices are used to manage or limit the uterine blood loss during PPH. Some of the devices used in the treatment of PPH include uniject prefilled injection systems, uterine balloon tamponade, and non-pneumatic anti-shock garment.
Increasing complications in pregnancy such as multiple pregnancies, inverted uterus, and large size of the baby are expected to propel growth of Asia Pacific postpartum hemorrhage (PPH) treatment devices market over the forecast period. For instance, according to The United Nations Children's Fund (UNICEF), June 2019 report, pregnancy-related complications are the major cause of death among adolescent girls in Africa, Asia, and Latin America and the Caribbean.
High number of cases of teen pregnancy are expected to offer lucrative growth opportunities for players in Asia Pacific postpartum hemorrhage (PPH) treatment devices market. For instance, according to March 2018 report of Plan International Australia, teen birth rates in Cambodia increased from 46 births in every 1000 in 2007 to 52 births per 1000 (5.2%) in 2015. Moreover, increasing prevalence of anemia in pregnant women is also expected to propel growth of the market. For instance, according to the study. ‘Prevalence and risk factors of anemia among pregnant women attending a public-sector hospital in Bangalore, South India’, published in the Journal of Family Medicine and Primary Care in January 2019, prevalence of anemia was 33.9% in the study population of pregnant women.
However, dearth of healthcare services in developing countries and high cost of PPH treatment devices are expected to hinder growth of the market.
Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in June 2019, PATH and Sinapi Biomedical announced that the Ellavi uterine balloon tamponade has achieved CE marking.
Key Takeaways:
- Increasing complications in pregnancy are expected to augment growth of Asia Pacific postpartum hemorrhage (PPH) treatment devices market over the forecast period
- High number cases of teen pregnancy are expected to offer lucrative growth opportunities for players in the market
- High cost of PPH treatment devices is expected to hinder growth of the market
- Major players operating in Asia Pacific postpartum hemorrhage (PPH) treatment devices market include Becton, Dickinson and Company, GE Healthcare, Bactiguard, R. Bard, Cook Medical, Davol, 3rd Stone Design, Teleflex Incorporated, Utah Medical Products, Zoex Niasg, and Inpress Technologies
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Postpartum Hemorrhage (PPH) Treatment Devices for these regions, from 2014 to 2025 (forecast), including
✑ China
✑ Japan
✑ South Korea
✑ Taiwan
✑ India
✑ Southeast Asia
✑ Australia
Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices market competition by top manufacturers/players, with Postpartum Hemorrhage (PPH) Treatment Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
✑ BD
✑ GE Healthcare
✑ Bactiguard
✑ R. Bard
✑ Cook Medical
✑ Davol
✑ 3rd Stone Design
✑ Teleflex Incorporated
✑ Utah Medical Products
✑ Program for Appropriate Technology In Health (Path)
✑ Zoex Niasg
✑ Inpress Technologies
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
✑ Non-pneumatic Anti-shock Garment (NASG)
✑ Uniject Prefilled Injection System
✑ Uterine Balloon Tamponade
✑ Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Postpartum Hemorrhage (PPH) Treatment Devices for each application, including
✑ Hospitals
✑ Clinics
✑ Other
** NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Report 2019
1 Postpartum Hemorrhage (PPH) Treatment Devices Overview
1.1 Product Overview and Scope of Postpartum Hemorrhage (PPH) Treatment Devices
1.2 Classification of Postpartum Hemorrhage (PPH) Treatment Devices by Product Category
1.2.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Size (Sales) Comparison by Types (2014-2025)
1.2.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Non-pneumatic Anti-shock Garment (NASG)
1.2.4 Uniject Prefilled Injection System
1.2.5 Uterine Balloon Tamponade
1.2.6 Other
1.3 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market by Application/End Users
1.3.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales (Volume) and Market Share Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market by Region
1.4.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Size (Value) Comparison by Region (2014-2025)
1.4.2 China Status and Prospect (2014-2025)
1.4.3 Japan Status and Prospect (2014-2025)
1.4.4 South Korea Status and Prospect (2014-2025)
1.4.5 Taiwan Status and Prospect (2014-2025)
1.4.6 India Status and Prospect (2014-2025)
1.4.7 Southeast Asia Status and Prospect (2014-2025)
1.4.8 Australia Status and Prospect (2014-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Postpartum Hemorrhage (PPH) Treatment Devices (2014-2025)
1.5.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales and Growth Rate (2014-2025)
1.5.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate (2014-2025)
2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices (Volume and Value) by Type
2.2.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices (Volume) by Application
2.4 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices (Volume and Value) by Region
2.4.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Market Share by Region (2014-2019)
3 China Postpartum Hemorrhage (PPH) Treatment Devices (Volume, Value and Sales Price)
3.1 China Postpartum Hemorrhage (PPH) Treatment Devices Sales and Value (2014-2019)
3.1.1 China Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate (2014-2019)
3.1.2 China Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate (2014-2019)
3.1.3 China Postpartum Hemorrhage (PPH) Treatment Devices Sales Price Trend (2014-2019)
3.2 China Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Type
3.3 China Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Application
4 Japan Postpartum Hemorrhage (PPH) Treatment Devices (Volume, Value and Sales Price)
4.1 Japan Postpartum Hemorrhage (PPH) Treatment Devices Sales and Value (2014-2019)
4.1.1 Japan Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate (2014-2019)
4.1.3 Japan Postpartum Hemorrhage (PPH) Treatment Devices Sales Price Trend (2014-2019)
4.2 Japan Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Type
4.3 Japan Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Application
5 South Korea Postpartum Hemorrhage (PPH) Treatment Devices (Volume, Value and Sales Price)
5.1 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Sales and Value (2014-2019)
5.1.1 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Sales Price Trend (2014-2019)
5.2 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Type
5.3 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Application
6 Taiwan Postpartum Hemorrhage (PPH) Treatment Devices (Volume, Value and Sales Price)
6.1 Taiwan Postpartum Hemorrhage (PPH) Treatment Devices Sales and Value (2014-2019)
6.1.1 Taiwan Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Postpartum Hemorrhage (PPH) Treatment Devices Sales Price Trend (2014-2019)
6.2 Taiwan Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Type
6.3 Taiwan Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Application
7 India Postpartum Hemorrhage (PPH) Treatment Devices (Volume, Value and Sales Price)
7.1 India Postpartum Hemorrhage (PPH) Treatment Devices Sales and Value (2014-2019)
7.1.1 India Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate (2014-2019)
7.1.2 India Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate (2014-2019)
7.1.3 India Postpartum Hemorrhage (PPH) Treatment Devices Sales Price Trend (2014-2019)
7.2 India Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Type
7.3 India Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Application
8 Southeast Asia Postpartum Hemorrhage (PPH) Treatment Devices (Volume, Value and Sales Price)
8.1 Southeast Asia Postpartum Hemorrhage (PPH) Treatment Devices Sales and Value (2014-2019)
8.1.1 Southeast Asia Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Postpartum Hemorrhage (PPH) Treatment Devices Sales Price Trend (2014-2019)
8.2 Southeast Asia Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Type
8.3 Southeast Asia Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Application
9 Australia Postpartum Hemorrhage (PPH) Treatment Devices (Volume, Value and Sales Price)
9.1 Australia Postpartum Hemorrhage (PPH) Treatment Devices Sales and Value (2014-2019)
9.1.1 Australia Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate (2014-2019)
9.1.3 Australia Postpartum Hemorrhage (PPH) Treatment Devices Sales Price Trend (2014-2019)
9.2 Australia Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Type
9.3 Australia Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Market Share by Application
10 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Players/Suppliers Profiles and Sales Data
10.1 BD
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 BD Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 GE Healthcare
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 GE Healthcare Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 Bactiguard
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Bactiguard Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 R. Bard
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 R. Bard Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
10.5 Cook Medical
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Cook Medical Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.5.4 Main Business/Business Overview
10.6 Davol
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Davol Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.6.4 Main Business/Business Overview
10.7 3rd Stone Design
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 3rd Stone Design Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.7.4 Main Business/Business Overview
10.8 Teleflex Incorporated
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Teleflex Incorporated Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.8.4 Main Business/Business Overview
10.9 Utah Medical Products
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Utah Medical Products Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.9.4 Main Business/Business Overview
10.10 Program for Appropriate Technology In Health (Path)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Postpartum Hemorrhage (PPH) Treatment Devices Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Program for Appropriate Technology In Health (Path) Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.10.4 Main Business/Business Overview
10.11 Zoex Niasg
10.12 Inpress Technologies
11 Postpartum Hemorrhage (PPH) Treatment Devices Manufacturing Cost Analysis
11.1 Postpartum Hemorrhage (PPH) Treatment Devices Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Postpartum Hemorrhage (PPH) Treatment Devices
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Postpartum Hemorrhage (PPH) Treatment Devices Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Postpartum Hemorrhage (PPH) Treatment Devices Major Manufacturers in 2018
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Forecast (2019-2025)
15.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume, Revenue and Price Forecast (2019-2025)
15.1.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate Forecast (2019-2025)
15.1.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate Forecast (2019-2025)
15.1.3 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Price and Trend Forecast (2019-2025)
15.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales Volume and Growth Rate Forecast by Region (2019-2025)
15.2.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.3 China Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.4 Japan Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.5 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.6 Taiwan Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.7 India Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.8 Southeast Asia Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.9 Australia Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.3 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales, Revenue and Price Forecast by Type (2019-2025)
15.3.1 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales Forecast by Type (2019-2025)
15.3.2 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Revenue Forecast by Type (2019-2025)
15.3.3 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Price Forecast by Type (2019-2025)
15.4 Asia-Pacific Postpartum Hemorrhage (PPH) Treatment Devices Sales Forecast by Application (2019-2025)
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
